Home > Income Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Consolidated Net Profit

    Back to Income Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹1,928 Cr₹2,648 Cr₹5,335 Cr₹2,845 Cr₹2,365 Cr

What is the latest Consolidated Net Profit of AUROBINDO PHARMA ?

The latest Consolidated Net Profit ratio of AUROBINDO PHARMA is ₹1,928 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹1,928 Cr
Mar2023₹2,648 Cr
Mar2022₹5,335 Cr
Mar2021₹2,845 Cr
Mar2020₹2,365 Cr

How is Consolidated Net Profit of AUROBINDO PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹1,928 Cr
-27.21
Mar2023 ₹2,648 Cr
-50.36
Mar2022 ₹5,335 Cr
87.51
Mar2021 ₹2,845 Cr
20.32
Mar2020 ₹2,365 Cr -

Compare Consolidated Net Profit of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹62,915.2 Cr -5.9% -10% -12.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,254.0 Cr -2.5% -4.9% 8.7% Stock Analytics
DIVIS LABORATORIES ₹172,374.0 Cr -2.7% -0.9% 42.5% Stock Analytics
CIPLA ₹119,795.0 Cr -1.5% 0.1% -4.3% Stock Analytics
DR REDDYS LABORATORIES ₹110,698.0 Cr -2.6% 8.3% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,218.0 Cr -2.6% -3.7% 11.9% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-5.9%

-10%

-12.1%

SENSEX

-0.4%

0.2%

5.9%


You may also like the below Video Courses